Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
NetEase (9999) heads into November earnings with short interest creeping higher on the week, borrowing costs ticking up, and the stock trading below analyst targets, a setup where the bears are re-engaging but the bulls have not capitulated.
Short sellers added meaningfully to their positions this week, with estimated shares short rising 8.5% over the past seven days to around 49.8 million shares. That follows a sharper unwind through most of September, when short interest fell more than 10% over the preceding month. The reversal began at the start of October, with the jump from roughly 46.3 million on October 1 to near 50 million by mid-week marking the most active rebuilding since late August. Cost to borrow has risen alongside the repositioning, climbing about 15% over the past month to 1.05%, its highest level in the period tracked. The move is measured rather than dramatic, borrowing remains cheap by any standard, but the direction is worth noting.
The lending market itself tells a very different story. Availability is exceptionally loose, with roughly 8,300% of current short interest available to borrow. That figure has actually fallen back over the week as more shares have been lent out, but it remains far above any level that would suggest squeeze risk. With over 1.5 billion shares available against fewer than 50 million short, there is ample room for bears to add further without facing borrow constraints. The ORTEX short score of 40, ranking in the 40th percentile, confirms this picture: short positioning is rebuilding but is nowhere near extreme.
What makes this week's setup interesting is the contrast between cautious price action and a Street that remains firmly positive. The consensus analyst recommendation ranks in the 100th percentile of the ORTEX universe, the most bullish reading possible, and the mean price target of HKD 216.93 implies roughly 15% upside from the current close of HKD 188.50. The stock is down about 2.1% on the week and flat over the past month, underperforming several peers: SEHK-listed 9899 fell 3.4% on the week and 1060 dropped 5.6%, while NYSE-listed TME managed a small 0.4% gain. On valuation, the trailing PE of 11.7x and EV/EBITDA of 7.1x are both modest by sector standards. The dividend score ranks in the 98th percentile, signalling a generous payout history, though the most recent dividend data in the snapshot dates to 2020, so that ranking likely reflects a longer historical record rather than a recent event.
Founder Lei Ding holds 45.3% of shares, a stake that has not changed as of the most recent filing in June, providing a stable anchor to the register. Among institutional holders, BlackRock added around 449,000 shares in the most recent period, Capital Research added over 2.2 million, and Hang Seng Investment Management added nearly 3.6 million, all modest additions pointing in the same direction as the analyst consensus. The insider data for the period is classified as stale, with the most recent trades recorded as administrative entries dated June 30, carrying no share counts or values, so insider conviction cannot be assessed from current data.
NetEase reports next on November 19. The one prior earnings event in the history data shows the stock gained 3.9% on the day before giving back most of that over the following five days, a pattern worth keeping in mind as the date approaches. Between now and then, the key question is whether the short interest rebuild continues at the same pace, and whether the gap between the HKD 188.50 price and the HKD 217 analyst target begins to close or widens further.
See the live data behind this article on ORTEX.
Open 9999 on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
